543 results on '"Kahlmeter, G."'
Search Results
2. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)
3. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
4. The quality of antimicrobial discs from nine manufacturers—EUCAST evaluations in 2014 and 2017
5. Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
6. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media
7. The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information
8. Coeliac disease and invasive pneumococcal disease : a population-based cohort study
9. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
10. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg
11. EUCAST evaluation of 21 brands of Mueller–Hinton dehydrated media for disc diffusion testing
12. EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin
13. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories
14. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
15. Invasive pneumococcal disease in patients with an underlying pulmonary Disorder
16. EUCAST expert rules in antimicrobial susceptibility testing
17. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates
18. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
19. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
20. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton
21. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk
22. Staphylococcus lugdunensis in several niches of the normal skin flora
23. Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions
24. Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes
25. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
26. The need for European professional standards and the challenges facing clinical microbiology
27. Jacques F. Acar (1931–2020)
28. Validation of EUCAST zone diameter breakpoints against reference broth microdilution
29. Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values
30. Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria
31. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
32. Welcoming countries emerging on the scene of medical sciences in Clinical Microbiology and Infection
33. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
34. Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex
35. Obituary: Johan Willem Mouton
36. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
37. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
38. Effects of temperature on the detection of methicillin resistance in Staphylococcus aureus using cefoxitin disc diffusion testing with Iso-Sensitest agar
39. The (r)evolution of clinical microbiology in Europe - is it good or bad?: S338
40. Implementation of European breakpoints and the future of EUCAST: S12
41. EUCAST disk diffusion Criteria for the Detection of mecA-Mediated ß-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin
42. Polyclonal distribution of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm: O432
43. Pseudomonas aeruginosa resistance rates in association with level of hospital care: data from the EARSS: O362
44. Is the ratio of associated Escherichia coli resistance comparable over Europe?: O359
45. A planned dramatic drop in trimethoprim consumption in a 180,000 population did not result in a related decrease in trimethoprim resistance in Escherichia coli: O164
46. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing
47. Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries
48. Fluoroquinolone resistance in invasive Escherichia coli in Europe is related to age and gender: P1788
49. E. coli and S. aureus-antimicrobial resistance surveillance and the effect of excluding duplicate isolates in a consecutive database 1990–2003: P1465
50. Changes in antimicrobial associated resistance, susceptibility patterns and ‘resistance load’ in 35,956 consecutive UTI Escherichia coli 1993–2003: P1463
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.